Vontrader why are you expecting an update from BLT in the next few days?
The company is trying to find suitable candidates to test it's TT-034 HCV drug. But problem is that first up it will test a sub-therapeutic dose. Once TT-034 is administered it cannot be readministered later, which means the first few people tested wont be cured and can't be given a therapeutic does later on. The company is already 2 months behind it's own timeline.
